What Happens to COVID-19 Tests after the EUA Pipeline Closes Down?
Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.
Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.
Abbott and Roche garnered the lion’s share of new 510(k) lab test approvals in 2022.
Here are what G2 Intelligence considers to be the 10 most significant FDA lab testing clearances of 2022, in rough chronological order.
A high volume of FDA approvals for new tests and diagnostic products made up for the relatively low number of approvals in the EU.
A roundup of the significant new diagnostic tests and products that received regulatory approval in the US and around the world.